← All trials
NCT03726593
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 4, 2018
- Primary completion
- Sep 30, 2020
- Completion date
- Jun 30, 2021
- First posted
- —
- Last posted
- —
- Enrollment
- 252
- Arms / groups
- 3 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Government of ThailandLead sponsor
- National Center for Parasitology, Entomology and Malaria ControlCollaborator
- Government of ThailandCollaborator
- Government of ThailandOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.